Clinical Trial

Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

Name: Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects — clinical trial record (NCT06658964)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated October 26, 2024 (before its estimated December 10, 2024 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the effects of oral administration rifampicin or itraconazole capsules on the pharmacokinetics of JMKX003142 in healthy subjects.

Trial Details

NCT Number	NCT06658964
Lead Sponsor	Jemincare Collaborators: Zhejiang Hangyu Pharmaceutical Co., Ltd.
Conditions	ADPKD (autosomal Dominant Polycystic Kidney Disease)
Enrollment	48 participants
Start Date	2024-11-05
Primary Completion	2024-12-10 (estimated)
Study Completion	2025-03-21 (estimated)
Updated on ClinicalTrials.gov	2024-10-26